Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulties

Sponsor
Nemours Children's Clinic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04599010
Collaborator
Children's Hospital Medical Center, Cincinnati (Other)
40
2
2
30
20
0.7

Study Details

Study Description

Brief Summary

Large for Gestational Age (LGA) infants have excess fat-mass (FM) proportion secondary to prolonged in utero exposure to an energy-rich environment. Our preliminary data suggest that excess FM proportion can be associated with oral feeding delay and a potentially modifiable therapeutic target to improve oral feeding outcomes. The objective of this study is to determine the impact of a short-term resting metabolic rate (RMR)-matched feeding on the oral intake volumes in LGA infants with oral feeding difficulties.

Condition or Disease Intervention/Treatment Phase
  • Other: Dietary intervention
Phase 2/Phase 3

Detailed Description

Eligible subjects will be randomized to an innovative RMR-matched feeding or the standard feeding for up to 2 weeks. The essential component of the RMR-matched feeding will be the difference in milk prescription dosing that we propose to set the feeding volume to index FFM rather than total mass. In RMR-matched feeding, there will be a permissive feeding volume restriction to 150 ± 10 mL/kg (FFM)/day without increasing the milk calorie density or changing the type of formula milk, whereas the standard feeding will include a feeding volume goal of 150 ± 10 mL/kg (body weight)/day. Infants will receive either breast milk or formula feedings per the standard feeding protocols. Body composition (PEAPOD system) and appetite-regulating hormones (ARH) levels of enrolled infants will be assessed at baseline (test-1) and at the end 2-week study intervention period (test-2). Subjects will be followed for clinical and growth outcomes until neonatal intensive care unit (NICU) discharge and through 6 months of age. Growth will be followed through 6 months of age by retrieving anthropometric measurement records from pediatricians at well-child visits (2-, 4-, 6- and 6-month visits). Parents will be called at these time points to obtain a history of any further feeding difficulties.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The sample size for this pilot study will be 40 with 20 infants randomized into each arm.The sample size for this pilot study will be 40 with 20 infants randomized into each arm.
Masking:
Single (Outcomes Assessor)
Masking Description:
The data analyzer will be masked to the allocation
Primary Purpose:
Treatment
Official Title:
Resting Metabolic Rate Matched Feeding in Large for Gestational Age Infants With Oral Feeding Difficulties
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: RMR-matched feeding

In RMR-matched feeding, there will be a permissive feeding volume restriction to 150 ± 10 mL/kg (FFM)/day without increasing the milk calorie density or changing the type of formula milk for 2 weeks.

Other: Dietary intervention
energy-restricted diet

Active Comparator: Standard feeding

The standard feeding approach will include an oral feeding volume goal of 150 ± 10 mL/kg/day during the 2-week study period

Other: Dietary intervention
energy-restricted diet

Outcome Measures

Primary Outcome Measures

  1. Days to oral feeding success [Before NICU-discharge]

    days from study entry to 'oral feeding success' defined as independent oral feeding for two consecutive days

Secondary Outcome Measures

  1. oral feeding volume at discharge [at NICU discharge]

    oral feeding volume (mL/kg/day) at discharge

  2. NICU Feeding related length of stay (LOS) [Before NICU discharge]

    Days from first oral feeding to independent oral feeding

  3. Gastrostomy rates [through study completion, an average of 2 year]

    Percentage of infants with gastrostomy placement

  4. ARH levels [2 weeks]

    Directional changes in ARH pre-post intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Week to 2 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • LGA infants with oral feeding difficulties born at ≥ 37 weeks gestation, with FM z-score > +1.0 in body composition measurement
Exclusion Criteria:
  • Infants on any respiratory support, Infants on enteral feeding duration > 60 minutes due to hypoglycemia concerns, videofluoroscopic swallow study (VFSS) demonstrating unsafe swallowing function, GI surgical conditions, significant neurological morbidities, and major congenital, genetic syndromes/anomalies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nemours Children's Hospital Orlando Florida United States 32827
2 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229

Sponsors and Collaborators

  • Nemours Children's Clinic
  • Children's Hospital Medical Center, Cincinnati

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nemours Children's Clinic
ClinicalTrials.gov Identifier:
NCT04599010
Other Study ID Numbers:
  • 871760
First Posted:
Oct 22, 2020
Last Update Posted:
Feb 8, 2022
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2022